- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT00263861
Nerve Function in Older Diabetic Patients Who Are Undergoing Chemotherapy for Metastatic Solid Tumors
Impact of Treatment With Taxane or Platinum-Containing Regimens on Peripheral Nerve Functioning in Older Cancer Patients With Diabetes: An Exploratory Study
RATIONALE: Learning about the side effects of chemotherapy may help plan treatment and may help patients live more comfortably.
PURPOSE: This clinical trial is studying nerve function in older diabetic patients who are undergoing chemotherapy for metastatic solid tumors.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
OBJECTIVES:
Primary
- Determine changes in peripheral nerve function in older patients with diabetes and metastatic solid tumors treated with taxane or platinum-containing chemotherapy regimens.
- Determine the extent to which age, pre-existing diabetes mellitus, and level of glycemic control predict a differential pattern in outcome beyond the effect of the drugs in patients treated with these regimens.
- Develop a clinical assessment that would predict whether or not patients with diabetes mellitus are more or less susceptible to the neurotoxic effects of chemotherapy.
OUTLINE: This is a longitudinal study.
Patients undergo an interview and clinical evaluation to measure demographic data, cutaneous sensation, gait and balance, vibration, lower extremity muscle strength, orthostatic blood pressure, and glycemic control. Patients are evaluated at baseline, every 3 weeks during chemotherapy for up to 4 treatments, and at 2 months after completion of treatment.
PROJECTED ACCRUAL: A total of 50 patients will be accrued for this study.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Ohio
-
Cleveland, Ohio, Estados Unidos, 44106-5047
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
DISEASE CHARACTERISTICS:
Diagnosis of solid tumor
- Metastatic disease (stage IV)
Planning neoadjuvant or adjuvant treatment of locoregional definitive or systemic therapy comprising ≥ 1 of the following:
- Taxane (paclitaxel or docetaxel)
- Platinum (cisplatin, carboplatin, or oxaliplatin)
- Diagnosis of type I or II diabetes mellitus
PATIENT CHARACTERISTICS:
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Other
- No other disease that reduces peripheral nerve function (e.g., HIV/AIDS, uremia, spinal injuries, alcoholism, or CNS problems)
PRIOR CONCURRENT THERAPY:
Chemotherapy
- See Disease Characteristics
- No prior chemotherapy
- No prior or concurrent neurotoxic drugs (i.e., vincristine)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
---|---|
Cutaneous sensation as measured by Semmes-Weinstein monofilaments
Prazo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Gait and balance as measured by Tinetti Performance Oriented Assessment of Gait and Balance Instrument
Prazo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Vibration as measured by tuning fork
Prazo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Lower extremity muscle strength as measured by Dynamometer
Prazo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Blood pressure changes
Prazo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Glycemic control as measured by Glycosylated Hemoglobin Assay
Prazo: baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
baseline, every 3 weeks for 4 courses, and then 2 months after completion of study treatment
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Constance Visovsky, PhD, RN, ACNP, Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- CWRU6Z03
- P30CA043703 (Concessão/Contrato do NIH dos EUA)
- CASE-CWRU-6Z03 (Outro identificador: Case Comprehensive Cancer Center)
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em management of therapy complications
-
Vyaire MedicalAinda não está recrutandoSíndrome de Insuficiência Respiratória do Recém-NascidoItália